Qingli Bie
- Immunology top 10%
- Molecular Biology
- Oncology
- Cancer Research top 10%
- Surgery
- Topics
- Immune Cell Function and Interaction (6 papers)IL-33, ST2, and ILC Pathways (5 papers)Eosinophilic Esophagitis (4 papers)
- Cited by
- ImmunologyCancer ResearchOncology
- Journals
- PLoS ONEOncogeneScientific Reports
In The Last Decade
Qingli Bie
31 papers receiving 739 citations
Peers
Comparison fields: 5 of 79
- Immunology 328
- Molecular Biology 298
- Oncology 182
- Cancer Research 161
- Surgery 155
Countries citing papers authored by Qingli Bie
This map shows the geographic impact of Qingli Bie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingli Bie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingli Bie more than expected).
Fields of papers citing papers by Qingli Bie
This network shows the impact of papers produced by Qingli Bie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingli Bie. The network helps show where Qingli Bie may publish in the future.
Co-authorship network of co-authors of Qingli Bie
This figure shows the co-authorship network connecting the top 25 collaborators of Qingli Bie. A scholar is included among the top collaborators of Qingli Bie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingli Bie. Qingli Bie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 7 | |
| 5 | 13 | |
| 6 | 2 | |
| 7 | 2 | |
| 8 | 7 | |
| 9 | 28 | |
| 10 | 29 | |
| 11 | 8 | |
| 12 | 19 | |
| 13 | 10 | |
| 14 | 42 | |
| 15 | 20 | |
| 16 | 16 | |
| 17 | 36 | |
| 18 | 61 | |
| 19 | 18 | |
| 20 | 21 |
About Qingli Bie
Qingli Bie is a scholar working on Cancer Research, Immunology and Biochemistry, having authored 35 papers that have together received 747 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (6 papers), IL-33, ST2, and ILC Pathways (5 papers) and Eosinophilic Esophagitis (4 papers). The work is most often cited by research in Immunology (328 citations), Cancer Research (161 citations) and Oncology (182 citations). Qingli Bie has collaborated with scholars based in China, Ghana and Hong Kong. Frequent co-authors include Bin Zhang, Shengjun Wang, Zhaoliang Su, Huaxi Xu, Yumin Wu, Haixin Dong, Zheng Dong, Huijian Yang, Wenrong Xu and Hui Qian. Their work appears in journals such as PLoS ONE, Oncogene and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.